toxylact: a03ba01 atropine

The first professional lActological database in the word

This monograph summarizes toxicity and lactation safety of atropine, the sole active substance in ATC class A03BA01, for use as web-based reference content for healthcare professionals.medpedia.framar+2

Classification and pharmacological group

·        Atropine is a naturally derived belladonna alkaloid with a tertiary amine structure, classified under ATC A03BA01 (belladonna alkaloids, tertiary amines, antispasmodics for functional gastrointestinal disorders).?atcddd.fhi+2

·        It is a competitive antagonist at muscarinic (M) cholinergic receptors, blocking parasympathetic activity in smooth muscle, cardiac tissue, secretory glands and the eye.ncbi.nlm.nih+3

Clinical indications and dosage context

·        Systemically, atropine is used for treatment of symptomatic sinus bradycardia and AV conduction disturbances, as premedication before anesthesia to reduce secretions and vagal reactions, and as an antidote in organophosphate, carbamate and muscarinic mushroom poisoning.rwandafda+3

·        It may also be used in ophthalmology for cycloplegia and mydriasis, and as an antispasmodic in functional gastrointestinal disorders, though GI use has become less common in many settings.wikipedia+3

Toxicodynamic profile

·        Atropine produces a characteristic antimuscarinic toxidrome: dry mouth, reduced secretions, flushed and hot dry skin, mydriasis with blurred vision and photophobia, tachycardia, urinary retention, constipation and anhidrosis.medpedia.framar+3

·        Central nervous system toxicity includes agitation, confusion, hallucinations, delirium, loss of coordination, and in severe cases psychotic reactions, seizures and coma, with elderly and infants particularly susceptible.ncbi.nlm.nih+3

·        Therapeutic intravenous doses in adults for bradycardia typically range around 0.5–1 mg, repeated every 3–5 minutes up to a course maximum of about 3 mg, while much higher cumulative doses may be required in organophosphate poisoning, titrated to drying of secretions and resolution of muscarinic signs.medicines+2

·        Overdose leads to marked tachyarrhythmias (including ventricular fibrillation), hyperthermia, severe CNS disturbances, urinary retention and ileus; management is supportive, with physostigmine considered in selected severe central anticholinergic toxicity.biomedpharmajournal+3

Special toxicity concerns and contraindications

·        Atropine is contraindicated or used with great caution in patients with narrow-angle glaucoma, prostatic hypertrophy with urinary retention, and gastric outlet obstruction (pyloric stenosis), because antimuscarinic effects can precipitate acute decompensation.wikipedia+2

·        It is also contraindicated in known hypersensitivity to atropine and related belladonna alkaloids, and many product labels list breastfeeding as a contraindication or warn strongly because of infant sensitivity and potential effects on lactation.medsafe+5

Lactation: pharmacokinetics and exposure

·        Atropine is excreted into human breast milk in small amounts; several product monographs note detectable levels and emphasize that nursing infants are highly sensitive to anticholinergic effects.docetp.mpa+5

·        The drug’s relatively short plasma half-life and limited single-dose exposure suggest that occasional systemic or ophthalmic use by the mother results in low infant exposure, especially if breastfeeding is timed away from peak maternal levels.ncbi.nlm.nih+2

Lactation: effects on the infant

·        Potential infant adverse effects include antimuscarinic symptoms such as reduced secretions, urinary retention, tachycardia, constipation, flushed dry skin, and possible CNS excitation or irritability, mirroring the adult toxidrome but at lower exposure thresholds.mohpublic.core.windows+4

·        Newborns and young infants are considered particularly vulnerable, and some regulatory documents caution that clinical effects in the breastfed child may occur even with small maternal doses, warranting close monitoring or temporary interruption of breastfeeding with higher or repeated dosing.docetp.mpa+3

Lactation: effects on milk production and let‑down

·        Chronic or repeated administration of atropine can reduce milk production and impair milk let‑down by inhibiting parasympathetic tone and potentially interfering with oxytocin-mediated milk ejection.medicines+6

·        Several product characteristics and regulatory texts explicitly state that atropine may inhibit lactation or the production of breast milk, reinforcing the need to avoid long-term use in nursing mothers when alternatives exist.medsafe+4

Evidence-based lactation safety assessment

·        The Drugs and Lactation Database (LactMed) indicates that a single systemic or ophthalmic dose of atropine is unlikely to interfere with breastfeeding, although long-term use can reduce milk production or let‑down; overall, occasional maternal use is considered compatible with breastfeeding under monitoring.ncbi.nlm.nih

·        Clinical guidelines from obstetric and neonatal care settings describe atropine as “considered safe to use” in breastfeeding when used in standard doses and on a short-term basis, with caution regarding repeated high-dose therapy and infant observation for anticholinergic symptoms.kemh.health+1

Practical lactation recommendations for A03BA01 drugs

·        For single-dose or short-course systemic use (e.g. perioperative premedication, treatment of bradycardia, antidote therapy), breastfeeding can usually continue, preferably avoiding nursing at 1–2 hours after dosing, and monitoring the infant for unusual dryness, poor feeding, or tachycardia.kemh.health+2

·        Prolonged therapy or high cumulative doses (such as intensive atropine regimens in organophosphate poisoning) may justify temporary interruption of breastfeeding and pumping to maintain supply, with individualized risk–benefit assessment and consideration of alternative agents when feasible.biomedpharmajournal+3

Key drug–drug interaction considerations (for toxicology context)

·        Atropine’s anticholinergic effects can be potentiated by other antimuscarinic or tricyclic agents, increasing toxicity risk; Framar’s interaction database lists numerous clinically significant interactions, including several strong ones, reflecting this cumulative anticholinergic burden.medpedia.framar+1

·        Conversely, atropine is intentionally combined with cholinesterase inhibitors (e.g. neostigmine) to balance muscarinic and nicotinic effects during reversal of neuromuscular blockade, requiring careful titration to avoid under- or over-antagonism.medicines+3

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.